Sight Sciences Company Insiders
| SGHT Stock | USD 7.71 0.23 3.07% |
Slightly above 93 percent of Sight Sciences' insiders are activelly selling. The analysis of insiders' sentiment of trading Sight Sciences stock suggests that a very large number of insiders are panicking at this time. Sight Sciences employs about 216 people. The company is managed by 22 executives with a total tenure of roughly 504 years, averaging almost 22.0 years of service per executive, having 9.82 employees per reported executive.
Insider Sentiment 7
Mostly Selling
Selling | Buying |
Latest Trades
| 2025-10-06 | Brenton Taylor | Disposed 591 @ 3.37 | View | ||
| 2025-10-03 | Jeremy B Hayden | Disposed 9731 @ 3.27 | View | ||
| 2025-10-01 | Paul Badawi | Disposed 24441 @ 3.34 | View | ||
| 2025-07-03 | Jeremy B Hayden | Disposed 9160 @ 4.17 | View | ||
| 2025-07-02 | Matthew Link | Disposed 4889 @ 4.1 | View | ||
| 2025-07-01 | Paul Badawi | Disposed 23637 @ 4.15 | View | ||
| 2025-04-02 | Matthew Link | Disposed 5042 @ 2.31 | View | ||
| 2025-04-01 | Paul Badawi | Disposed 24174 @ 2.3 | View | ||
| 2025-03-12 | Manohar K Raheja | Acquired 10000 @ 2.73 | View | ||
| 2025-01-17 | Jeremy B Hayden | Disposed 6922 @ 2.78 | View | ||
| 2025-01-16 | Paul Badawi | Disposed 24819 @ 2.92 | View | ||
| 2025-01-08 | Jeremy B Hayden | Disposed 1810 @ 3.26 | View | ||
| 2025-01-03 | Jeremy B Hayden | Disposed 4864 @ 3.52 | View | ||
| 2025-01-02 | Paul Badawi | Disposed 12236 @ 3.6 | View |
Monitoring Sight Sciences' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sight Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. Sight Sciences Management Team Effectiveness
The company has return on total asset (ROA) of (0.2047) % which means that it has lost $0.2047 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5791) %, meaning that it created substantial loss on money invested by shareholders. Sight Sciences' management efficiency ratios could be used to measure how well Sight Sciences manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.34 in 2026. Return On Capital Employed is likely to drop to -0.37 in 2026. At this time, Sight Sciences' Non Current Liabilities Total is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 4.4 M in 2026, whereas Total Current Liabilities is likely to drop slightly above 12.3 M in 2026.Common Stock Shares Outstanding is likely to drop to about 48.2 M in 2026. Net Loss is likely to gain to about (73.7 M) in 2026Sight Sciences shows a total of 52.87 Million outstanding shares. Sight Sciences maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Shares in Circulation | First Issued 2020-03-31 | Previous Quarter 51.8 M | Current Value 52.4 M | Avarage Shares Outstanding 45.8 M | Quarterly Volatility 5.9 M |
Sight Sciences Workforce Comparison
Sight Sciences is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 27,062. Sight Sciences maintains roughly 216 in number of employees contributing less than 1% to equities under Health Care industry.
Sight Sciences Profit Margins
The company has Profit Margin (PM) of (0.61) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.26) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.26.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.62 | 0.77 |
|
|
Sight Sciences Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Sight Sciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Sight Sciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Sight Sciences insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2025-12-01 | 0.5833 | 7 | 12 | 100,301 | 171,240 |
| 2025-09-01 | 0.2857 | 2 | 7 | 65,840 | 140,117 |
| 2025-06-01 | 3.0 | 18 | 6 | 597,372 | 77,054 |
| 2025-03-01 | 1.1 | 11 | 10 | 1,612,555 | 85,163 |
| 2024-12-01 | 0.7 | 7 | 10 | 822,802 | 670,129 |
| 2024-06-01 | 1.0 | 6 | 6 | 104,196 | 47,195 |
| 2023-12-01 | 7.0 | 14 | 2 | 2,409,118 | 3,002,036 |
| 2023-09-01 | 1.0 | 2 | 2 | 37,668 | 37,668 |
| 2023-03-01 | 2.125 | 17 | 8 | 968,400 | 22,753 |
| 2022-09-01 | 0.3333 | 1 | 3 | 40,000 | 4,426,670 |
| 2022-06-01 | 7.0 | 7 | 1 | 364,700 | 120,000 |
| 2021-09-01 | 0.2683 | 11 | 41 | 23,124,699 | 22,429,105 |
Sight Sciences Notable Stakeholders
A Sight Sciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Sight Sciences often face trade-offs trying to please all of them. Sight Sciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Sight Sciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| David MD | CTO CoFounder | Profile | |
| James Rodberg | Principal CFO | Profile | |
| Alison Bauerlein | CFO Treasurer | Profile | |
| Jim Rodberg | VP Controller | Profile | |
| Steve Tamayo | VP Officer | Profile | |
| MBA BS | VP Operations | Profile | |
| Stacie Rodgers | VP HR | Profile | |
| John Liu | VP Access | Profile | |
| Stephen JD | Secretary | Profile | |
| Reay MD | Chief Officer | Profile | |
| Sam Park | Chief Officer | Profile | |
| John Ordway | VP Operations | Profile | |
| Brenton Taylor | Executive Operations | Profile | |
| Matthew Link | Chief Officer | Profile | |
| Mark Papini | Senior Glaucoma | Profile | |
| Jeremy JD | Chief Secretary | Profile | |
| Paul Badawi | President, CoFounder | Profile | |
| Tom Huang | Head Development | Profile | |
| Reay Brown | Chief Officer | Profile | |
| Jesse Selnick | Chief Officer | Profile | |
| Jeremy Hayden | Chief Officer | Profile | |
| Manohar Raheja | Executive Development | Profile |
About Sight Sciences Management Performance
The success or failure of an entity such as Sight Sciences often depends on how effective the management is. Sight Sciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Sight management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Sight management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.32) | (0.34) | |
| Return On Capital Employed | (0.36) | (0.37) | |
| Return On Assets | (0.32) | (0.34) | |
| Return On Equity | (0.68) | (0.64) |
Please note, the imprecision that can be found in Sight Sciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Sight Sciences. Check Sight Sciences' Beneish M Score to see the likelihood of Sight Sciences' management manipulating its earnings.
Sight Sciences Workforce Analysis
Traditionally, organizations such as Sight Sciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Sight Sciences within its industry.Sight Sciences Manpower Efficiency
Return on Sight Sciences Manpower
| Revenue Per Employee | 369.8K | |
| Revenue Per Executive | 3.6M | |
| Net Loss Per Employee | 238.5K | |
| Net Loss Per Executive | 2.3M | |
| Working Capital Per Employee | 575.5K | |
| Working Capital Per Executive | 5.7M |
Additional Tools for Sight Stock Analysis
When running Sight Sciences' price analysis, check to measure Sight Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sight Sciences is operating at the current time. Most of Sight Sciences' value examination focuses on studying past and present price action to predict the probability of Sight Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sight Sciences' price. Additionally, you may evaluate how the addition of Sight Sciences to your portfolios can decrease your overall portfolio volatility.